Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01749670 · ClinicalTrials.gov registry record
Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 45
- Enrollment target
NCT01749670 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 45 participants.
The verdict
NCT01749670 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
There is accumulating evidence that genetic expression plays a role in autism spectrum disorder, but the regulation of such genes is poorly understood. Small RNA particles, called microRNA (miRNA), have the ability to alter gene expression. These particles can be packaged and released from brain cells into the blood. Changes in miRNA may contribute to the patterns observed in autism spectrum disorder. The purpose of this study is to identify small RNA particles that regulate gene expression in autism spectrum disorder. The goal is to identify miRNA expression patterns which may improve our understanding and diagnosis of autism spectrum disorder.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01749670
The ClinicalTrials.gov registry entry for NCT01749670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01749670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01749670 about?
NCT01749670 is a clinical study titled "Exosomal MicroRNA Expression in Children With Autism Spectrum Disorder". There is accumulating evidence that genetic expression plays a role in autism spectrum disorder, but the regulation of such genes is poorly understood. Small RNA particles, called microRNA (miRNA), have the ability to alter gene expression. These particles can be packaged and released from brain cel...
What is the current status of trial NCT01749670?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2013-01. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01749670?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.